Empagliflozin improves kidney senescence induced by d-galactose by reducing sirt1-mediated oxidative stress
Ronghua Fang, Jie Chen, Jiangchuan Long, Binghan Zhang, Qixuan Huang, Shengbing Li, Ke Li, Qing Chen, Dongfang Liu
Topics & Concepts
EmpagliflozinOxidative stressSenescenceAgeingSOD2EndocrinologyInternal medicinePharmacologyMedicineDiabetes mellitusSuperoxide dismutaseType 2 diabetesAntioxidants, Aging, Portulaca oleraceaAdvanced Glycation End Products researchMetabolism, Diabetes, and Cancer